関連する実験動画

Updated: Sep 9, 2025

Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability

Performing Permanent Distal Middle Cerebral with Common Carotid Artery Occlusion in Aged Rats to Study Cortical Ischemia with Sustained Disability

Published on: February 23, 2016

中年における罹病率クラスターのインシデンスと重度の役割:ARIC研究

Marco Egle¹, Renee C Groechel¹, Michelle C Johansen²

¹Stroke Branch, National Institute of Neurological Disorders and Stroke, Intramural Research Program, National Institutes of Health, Bethesda, MD (M.E., R.C.G., R.F.G.).

|September 4, 2025

まとめ

中年期の健康クラスターは脳卒中のリスクと重症度に大きな影響を与えます腎機能不全のクラスターは,全体的な脳卒中と中等重度の脳卒中のリスクが最も高かった.

科学分野:

心血管伝染病学
医療における機械学習
脳卒中の予防

背景:

中年の血管疾患のリスクは将来の脳卒中リスクと強く関連しています
併発する危険因子に基づいて患者様を特定することで脳卒中リスクの予測を精密にすることができます
機械学習は複雑な健康特性を用いて人口を階層化するための新しいアプローチを提供します

研究の目的:

機械学習のクラスター分析を適用し,異なるミッドライフの臨床プロフィールを特定します.
これらの特定されたクラスターとインシデント・ストロックのリスクを評価する.
中年期のクラスターと脳卒中の重度の関係を評価する

主な方法:

中年の血管の危険因子に基づくARIC研究から15,404人の参加者の無監督の集積的階層的クラスタリング.
特徴 (高血圧,糖尿病,腎機能障害など) に基づく9つの異なるクラスタの特徴付け
コックス比例リスクモデルと多項論理回帰により,脳卒中発生率と重症度の関連性を分析 (NIHSS格付け).

主要な成果:

比較的健康な状態から喫煙,心血管疾患,腎臓機能不全などの特定の状態によって定義されるまで 9つの異なる中年健康クラスターが特定されました
比較的に健康なグループを除く全てのクラスタは脳卒中リスクの増加と関連しており,腎機能不全 (クラスタ9) は最も高いリスク (HR 3. 00) と中等重度の脳卒中 (HR 4. 78) と関連している.
ほとんどのクラスターは70歳以前に脳卒中のリスクが高く,クラスター5 (肥満,糖尿病,高血圧,高血糖症) もどの年齢でも脳卒中リスクに関連していた.

結論:

中年期の健康クラスターは特に多発性合併症のクラスターは将来の脳卒中の発生率と重度の決定要因です
腎機能不全などの特定のクラスターは,標的型予防戦略を必要とする高リスクグループを表しています.
中年期の罹患パターンを理解することでパーソナライズされた脳卒中の予防と管理に役立つかもしれません

キーワード:

動脈硬化症心房細動高血圧発血性脳卒中ストローク

さらに関連する動画

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Author Spotlight: Assessing Ischemic Stroke Damage Through Middle Cerebral Artery Occlusion Model

Published on: August 11, 2023

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

A Magnetic Resonance Imaging-based Computational Protocol for Analysis of Plaque Morphology and Hemodynamics in Patients with Carotid Artery Stenosis

Published on: August 12, 2025

関連する概念動画

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Atherosclerosis IV: Nursing Management

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...

Coronary Artery Disease I: Introduction

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...

Atherosclerosis I: Introduction

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...

Atherosclerosis III: Management

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...